Paid Clinical Trials and Focus Groups by Location |
|
|
|
Conditions: Cervical Neoplasia; HPV Infections
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - verified January 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Canagliflozin 100 mg; Drug: Placebo/sitagliptin 2x50 mg; Drug: Canagliflozin 300 mg
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting - verified March 2010